DE69333624D1 - Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee - Google Patents

Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee

Info

Publication number
DE69333624D1
DE69333624D1 DE69333624T DE69333624T DE69333624D1 DE 69333624 D1 DE69333624 D1 DE 69333624D1 DE 69333624 T DE69333624 T DE 69333624T DE 69333624 T DE69333624 T DE 69333624T DE 69333624 D1 DE69333624 D1 DE 69333624D1
Authority
DE
Germany
Prior art keywords
phyto
isoflavon
clover
soya
estrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69333624T
Other languages
English (en)
Other versions
DE69333624T2 (de
Inventor
Graham Edmund Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novogen Research Pty Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3776175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69333624(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69333624D1 publication Critical patent/DE69333624D1/de
Publication of DE69333624T2 publication Critical patent/DE69333624T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/05Mashed or comminuted pulses or legumes; Products made therefrom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/05Mashed or comminuted pulses or legumes; Products made therefrom
    • A23L11/07Soya beans, e.g. oil-extracted soya bean flakes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11Plant sterols or derivatives thereof, e.g. phytosterols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
DE69333624T 1992-05-19 1993-05-19 Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee Expired - Lifetime DE69333624T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPL251192 1992-05-19
AU2511992 1992-05-19
PCT/AU1993/000230 WO1993023069A1 (en) 1992-05-19 1993-05-19 Health supplements containing phyto-oestrogens, analogues or metabolites thereof

Publications (2)

Publication Number Publication Date
DE69333624D1 true DE69333624D1 (de) 2004-10-21
DE69333624T2 DE69333624T2 (de) 2005-09-15

Family

ID=3776175

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333624T Expired - Lifetime DE69333624T2 (de) 1992-05-19 1993-05-19 Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee

Country Status (14)

Country Link
US (12) USRE40792E1 (de)
EP (2) EP0656786B2 (de)
JP (2) JPH07506822A (de)
AT (1) ATE275959T1 (de)
AU (1) AU683838B2 (de)
BR (1) BR9306393A (de)
CA (1) CA2136233C (de)
DE (1) DE69333624T2 (de)
DK (1) DK0656786T3 (de)
ES (1) ES2225822T3 (de)
NO (1) NO944435L (de)
NZ (1) NZ252051A (de)
PT (1) PT656786E (de)
WO (1) WO1993023069A1 (de)

Families Citing this family (184)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07506822A (ja) 1992-05-19 1995-07-27 ノボゲン リサーチ ピーティーワイ リミッテッド フィト−エストロゲン,類似体またはその代謝産物を含有する健康補助剤
CA2160371A1 (en) * 1993-04-16 1994-10-27 The Trustees Of Tufts College Method for treatment of menopausal and premenstrual symptoms
US6140469A (en) * 1993-10-12 2000-10-31 Protein Technologies International, Inc. Protein isolate having an increased level of isoflavone compounds and process for producing the same
US5885632A (en) * 1993-12-14 1999-03-23 Nichimo Co., Ltd. Process for preparing a product from a pulse crop as a starting material and a food containing the product prepared from a pulse crop as a starting material
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5911995A (en) * 1994-08-19 1999-06-15 Regents Of The University Of Minnesota EGF-genistein conjugates for the treatment of cancer
US5587459A (en) * 1994-08-19 1996-12-24 Regents Of The University Of Minnesota Immunoconjugates comprising tyrosine kinase inhibitors
US6060101A (en) * 1994-09-02 2000-05-09 Designing Health, Inc. Dietary food supplement
US5656312A (en) * 1994-09-02 1997-08-12 Erasmus; Udo Dietary food supplement and method of preparing
US6001401A (en) * 1994-09-02 1999-12-14 Designing Health, Inc. Food supplement composition
WO1996010341A1 (en) * 1994-10-03 1996-04-11 Schouten Industries B.V. Food and health products
US6261565B1 (en) 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US6391310B1 (en) 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
US6015785A (en) * 1996-04-12 2000-01-18 Protein Technologies International, Inc. Aglucone isofavone enriched vegetable protein extract and isolate and process for producing
US5821361A (en) 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
AU3887597A (en) * 1996-07-18 1998-02-10 Nutricor, Inc. Nutritious food preparations and methods for making them
AU718218B2 (en) * 1996-07-30 2000-04-13 Energetics Inc. Dietary supplements
US6040333A (en) * 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
US6579561B2 (en) 1996-08-09 2003-06-17 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable flour and vegetable grit and process for making the same from a vegetable material containing isoflavone
US6521282B1 (en) 1996-08-09 2003-02-18 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable flour and grit
AU2004224982B2 (en) * 1996-08-30 2007-09-13 Novogen Research Pty Ltd Therapeutic methods and compositions involving isoflavones
AU2007201805B2 (en) * 1996-08-30 2009-03-26 Novogen Research Pty Ltd Therapeutic methods and compositions involving isoflavones
AU731951B2 (en) * 1996-08-30 2001-04-05 Novogen Research Pty Ltd Therapeutic methods and compositions involving isoflavones
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US5762936A (en) * 1996-09-04 1998-06-09 Biotics Research Corporation Antioxidant derived from lentil and its preparation and uses
JP2829387B2 (ja) * 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
US6060063A (en) * 1996-12-31 2000-05-09 Lansky; Ephraim Philip Phytoestrogen supplements prepared from pomegranate material including pomegranate seeds
FR2761264B1 (fr) 1997-03-26 1999-10-15 Serobiologiques Lab Sa Utilisation d'extrait(s) de graines de pois bambara dans une composition cosmetique et composition cosmetique correspondante
WO1998048790A1 (en) * 1997-04-28 1998-11-05 Anticancer, Inc. Use of genistein and related compounds to treat certain sex hormone related conditions
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
AU779210B2 (en) * 1997-05-01 2005-01-13 Novogen Inc Treatments or prevention of menopausal symptoms and osteoporosis
EP0979074A4 (de) * 1997-05-01 2003-07-09 Novogen Inc Behandlung oder vorbeugung klimakteriumsymptomen und der osteoporose
US6030620A (en) * 1997-07-25 2000-02-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing an organic extract of chick pea
FI107014B (fi) * 1997-07-25 2001-05-31 Oriola Oy Terveysravintovalmiste
DE19732855C2 (de) * 1997-07-30 1999-11-11 Indena Spa Spezieller Soja-Extrakt, dessen Herstellung, diesen enthaltende Formulierungen und deren Verwendung für die Prävention oder Behandlung von Krebs
KR100388511B1 (ko) 1997-07-30 2003-06-25 인데나 에스.피.에이 대두 추출물, 그의 제조 방법 및 약학 조성물
DE19732866C2 (de) * 1997-07-30 1999-11-04 Indena Spa Neue Soja-Extrakte, ihre Herstellung, auf ihnen basierende Formulierungen und deren Verwendung für die Prävention oder Behandlung von pre-menopausalen und post-menopausalen Symptomen
US5855892A (en) * 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US5952374A (en) * 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
AUPP198798A0 (en) * 1998-02-25 1998-03-19 Novogen Research Pty Ltd Compositions comprising extracts of isoflavone-containing plants and anti-cancer modalities involving the same
US6004558A (en) * 1998-02-25 1999-12-21 Novogen, Inc. Methods for treating cancer with legume plant extracts
EP1321146A3 (de) * 1998-03-11 2004-06-02 Endorecherche Inc. Typ 5 und Typ 3 17 Beta-Hydroxisteroid-Dehydrogenasehemmer und Verfahren zu ihrer Anwendung
US6132795A (en) * 1998-03-15 2000-10-17 Protein Technologies International, Inc. Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material
AUPP260798A0 (en) 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AU3456499A (en) * 1998-03-30 1999-10-18 University Of Mississippi, The Isoflavones for treating giardiasis and malaria
US6083553A (en) * 1998-06-05 2000-07-04 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
EP1438900A1 (de) * 1998-07-16 2004-07-21 Aaron Tabor Verwendung von Sojazubereitungen in Lebensmittelzusammensetzungen
CN1184895C (zh) * 1998-07-16 2005-01-19 阿龙·塔博尔 大豆组合物及其促进健康的应用
WO2000016759A2 (en) * 1998-09-17 2000-03-30 Guido Schnyder Genistein for the treatment of coronary heart disease and for the prevention of restenosis after percutaneous transluminal coronary angioplasty
US6703051B1 (en) 1998-10-13 2004-03-09 Solae, Llc Process for separating and recovering protein and isoflavones from a plant material
JP2000119187A (ja) * 1998-10-15 2000-04-25 Taisho Pharmaceut Co Ltd 抑うつ気分の予防または改善用組成物
AU767245B2 (en) 1998-11-25 2003-11-06 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
AU1404600A (en) 1998-11-25 2000-06-13 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases
ATE307601T1 (de) * 1998-12-07 2005-11-15 Ecosmart Technologies Inc Brustkrebsbehandlung mittels natürlicher ätherischer öle
ATE236720T1 (de) * 1999-02-24 2003-04-15 Bijam Biosciences Ltd Neues agropolymer zur reinigung von verunreinigtem oder mit metall oder ionen kontaminiertem wasser und verfahren zur herstellung desselben
US6413546B1 (en) 1999-03-18 2002-07-02 Indena, S.P.A. Tablets incorporating isoflavone plant extracts and methods of manufacturing them
US6387418B1 (en) 1999-04-19 2002-05-14 Stewart And Lynda Resnick Revocable Trust Pomegranate extracts and methods of using thereof
AU3398200A (en) * 1999-03-22 2000-10-09 Stewart And Lynda Resnick Revocable Trust Pomegranate extracts and methods of using thereof
US7727563B2 (en) 1999-04-19 2010-06-01 Pom Wonderful, Llc Methods of using pomegranate extracts for treating diabetes related atherosclerotic complications in humans
US8372454B2 (en) * 1999-04-19 2013-02-12 Pom Wonderful Llc Methods of making pomegranate compounds for the treatment of erectile dysfunction
US6641850B1 (en) 1999-04-19 2003-11-04 Stewart And Lynda Resnick Revocable Trust Methods of using pomegranate extracts for causing regression in lesions due to arteriosclerosis in humans
AU777254B2 (en) 1999-04-20 2004-10-07 Board Of Trustees Of Southern Illinois University, The Methods of treating clinical diseases with isoflavones
US6544566B1 (en) 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US7285297B1 (en) 1999-04-23 2007-10-23 Archer-Daniels-Midland Company Method of reducing low density liproprotein cholesterol concentration
AU761047B2 (en) * 1999-04-28 2003-05-29 Novogen Research Pty Ltd Cardiovascular and bone treatment using isoflavones
AUPQ008399A0 (en) * 1999-04-28 1999-05-27 Novogen Research Pty Ltd Cariovascular applications
US20040072765A1 (en) * 1999-04-28 2004-04-15 Novogen Research Pty Ltd. Cardiovascular and bone treatment using isoflavones
US6878859B1 (en) 1999-05-20 2005-04-12 The Samuel Roberts Noble Foundation, Inc. Isoflavonoid methylation enzyme
WO2000071736A1 (en) * 1999-05-20 2000-11-30 The Samuel Roberts Noble Foundation, Inc. Isoflavonoid methylation enzyme
ATE322903T1 (de) * 1999-07-09 2006-04-15 Sun Farm Corp Diätzusatz zur behandlung von malignitäten und virusinfektionen und verbesserung der immunfunktion
US20090233999A1 (en) * 1999-09-06 2009-09-17 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ266199A0 (en) 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
US6534085B1 (en) * 1999-09-23 2003-03-18 Bioresponse L.L.C. Phytochemicals for promoting weight loss
US7384971B2 (en) 1999-09-23 2008-06-10 Bioresponse L.L.C. Phytochemicals for the treatment of cervical dysplasia
US6689387B1 (en) * 1999-09-23 2004-02-10 Bioresponse Llc Phytochemicals for treatment of mastalgia and endometriosis
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
IL135335A (en) * 2000-03-29 2013-12-31 Lycored Natural Prod Ind Ltd Use of Carotenoids in Preparing Pharmaceuticals to Prevent Adverse Effects from Hormones and Pharmaceuticals Containing Carotenoids
WO2001074345A2 (en) * 2000-03-31 2001-10-11 Jonathan Ingram Isoflavones for treatment of obesity
US7939115B2 (en) * 2000-06-12 2011-05-10 Access Business Group International Llc Dietary supplement and related method
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
US6989161B2 (en) * 2000-06-12 2006-01-24 Access Business Group International Llc Phytonutrient nutritional supplement
US7416749B2 (en) * 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
US6511675B2 (en) 2000-06-12 2003-01-28 Access Business Group International, Llc Composition and method for correcting a dietary phytochemical deficiency
KR20020060070A (ko) * 2000-07-18 2002-07-16 아키라 이가키 간세포 증강제
EP1174144A1 (de) 2000-07-20 2002-01-23 Linnea S.A. Trockenextrakt reich in Isoflavonen und Verfahren zur Herstellung
US6552085B2 (en) * 2000-08-16 2003-04-22 Insmed Incorporated Compositions containing hypoglycemically active stilbenoids
US6410596B1 (en) * 2000-08-16 2002-06-25 Insmed Incorporated Compositions containing hypoglycemically active stillbenoids
US6326366B1 (en) * 2000-08-22 2001-12-04 Protein Technologies International Hormone replacement therapy
US7734724B2 (en) * 2000-09-06 2010-06-08 Xanboo Inc. Automated upload of content based on captured event
AU2000276898A1 (en) * 2000-09-29 2002-04-22 Jae-Seung Roh Method for manufacturing green elemental bean sprouts using yellow light
CN1250106C (zh) 2000-11-09 2006-04-12 卡吉尔公司 大豆加工
KR20020037140A (ko) * 2000-11-13 2002-05-18 권승룡 지질 저하 활성을 갖는 플라보노이드를 포함하는 터몹시스알터니플로라 추출물 및 이를 유효 성분으로 하는 약학적조성물
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
US20030190381A1 (en) * 2001-02-02 2003-10-09 Bland Jeffrey S. Medical composition for balancing bodily processes
US20040220118A1 (en) * 2001-02-02 2004-11-04 Bland Jeffrey S. Medical composition for balancing bodily processes
US20070059378A1 (en) * 2001-02-02 2007-03-15 Metagenics, Inc. Medical composition for balancing bodily processes
US20060034954A1 (en) * 2001-02-02 2006-02-16 Bland Jeffrey S Medical composition for balancing bodily processes
CN1273608C (zh) * 2001-02-09 2006-09-06 荷兰联合利华有限公司 通过发酵制备一种或多种抑制素的方法
US20020160079A1 (en) * 2001-02-28 2002-10-31 Kim Tae-Hyun Koji produced from soybean hypocotyl, preparation method thereof, and soy hypocotyl products prepared from said koji
AUPR363301A0 (en) * 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
US20050119301A1 (en) * 2001-03-16 2005-06-02 Alan Husband Treatment of restenosis
WO2002101023A2 (en) * 2001-06-13 2002-12-19 E.I. Du Pont De Nemours And Company A method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant
US6787151B2 (en) 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
US7338971B2 (en) * 2001-08-30 2008-03-04 El-Naggar Mawaheb M Treatment of inflammatory, cancer, and thrombosis disorders
US7348352B2 (en) * 2001-10-23 2008-03-25 Bioresponse L.L.C. Diindolylmethane for the treatment of HPV infection
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
EP1310261A1 (de) * 2001-11-09 2003-05-14 Cognis France S.A. Verwendung eines Extraktes der Vigna aconitifolia-Pflanze in einer Kosmetischen und/oder dermopharmazeutischen Zusammensetzung
PL352591A1 (en) * 2002-03-04 2003-09-08 Medana Pharma Terpol Group S.A. Permanent pharmaceutical oral dosed form and method of manufacture of permanent pharmaceutical oral dosed form
EP1491192A4 (de) * 2002-03-15 2007-08-15 Nichimo Kk Die biologische wirkung fördernde zusammensetzungen mit isoflavon-agklykon aus sojabohnenkeimen
US7048960B2 (en) 2002-03-22 2006-05-23 Glenn Roy Pizzey High lignan flaxseed product and product by process
KR101238752B1 (ko) * 2002-04-18 2013-03-06 몬산토 테크놀로지 엘엘씨 심혈관 질환의 위험성을 감소시키기 위한 오일 바디 결합 단백질 조성물 및 이의 사용 방법
JP2006504409A (ja) 2002-07-24 2006-02-09 チルドレンズ ホスピタル メディカル センター 鏡像異性のエクオールを含有する組成物および製品、およびその製造方法
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
AU2003255232A1 (en) 2002-08-07 2004-02-25 University Of Mississippi Antigiardial agents and use thereof
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
AU2003286781B2 (en) 2002-10-29 2009-05-21 Brigham Young University Use of equol for treating androgen mediated diseases
EP1623707A4 (de) * 2002-11-21 2007-04-04 Nichimo Kk Medizinische zusammensetzung zur behandlung von plötzlicher taubheit
WO2004080474A1 (en) * 2003-03-06 2004-09-23 The Medical Research And Education Trust Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising prenyl flavonoids
KR100868904B1 (ko) * 2003-03-27 2008-11-14 (주)아모레퍼시픽 대두배아 이소플라본 어글리콘, 석류추출물 및 세코이소라리시레시놀로 이루어진 IB complex를 함유하는 피부 주름 개선 및 탄력 증진용 외용제 조성물
US20040228931A1 (en) * 2003-05-12 2004-11-18 Pharmachem Laboratories, Inc. Novel composition for hormonal balance and uses thereof
US7025998B2 (en) 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
EP1541040A1 (de) * 2003-12-04 2005-06-15 Cognis Iberia S.L Zubereitung zur oralen Aufnahme (VI) enthaltend einen Extrakt oder Wirkstoffe der Pflanze Medicago sativa
US20050152887A1 (en) * 2004-01-14 2005-07-14 Doctor's Signature Sales And Marketing International Corp. [Dba Life Force International Protonic formulation
JP2005229855A (ja) * 2004-02-18 2005-09-02 Pola Chem Ind Inc 食品組成物
US20050220949A1 (en) * 2004-03-31 2005-10-06 Blas Arzubi Highly bioefficient isoflavone-phospholipid molecular complexes and methods of making and using the same
EP1740191A4 (de) * 2004-04-28 2008-07-30 Univ Brigham Young Verwendung von equol zur behandlung von hauterkrankungen
US8663679B2 (en) 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
US8377484B1 (en) 2004-05-06 2013-02-19 Maria V. Tsiper Tumor encapsulation for prevention and treatment of metastatic cancer disease
BRPI0510717B8 (pt) * 2004-05-06 2021-05-25 Bioresponse Llc uso de 3,3' diindolilmetano (dim) ou 2-(indol-3-ilmetil)-3,3´-diindolilmetano (ltr)
MXPA06013137A (es) * 2004-05-10 2007-05-16 Itesm Inhibicion del crecimiento celular cancerigenos a traves de extractos de frijol negro (phaseolus vulgarisl).
US7727560B2 (en) * 2004-05-18 2010-06-01 Sou Yi Lu Treating cancer, liver, kidney, platelet and hemopoietic disorder or complication
US7433359B2 (en) * 2004-05-28 2008-10-07 Fujitsu Limited Application of an Ethernet/MPLS half bridge to provide Ethernet multiplexing functions (EMF) in SONET network elements (NEs)
ITMI20041342A1 (it) 2004-07-05 2004-10-05 Marfarma Holding S P A Estratto di trigoflio rosso arricchito in equolo per fermentazione
US7601370B2 (en) * 2004-07-28 2009-10-13 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
KR20070050458A (ko) * 2004-07-28 2007-05-15 아보트 러보러터리즈 영양섭취용 조성물 및 골다공증의 치료 또는 예방 방법
US7435431B2 (en) * 2004-07-28 2008-10-14 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
CN101031292A (zh) * 2004-09-30 2007-09-05 不二制油株式会社 性激素结合球蛋白抑制组合物
US20150005360A1 (en) 2004-10-25 2015-01-01 Nse Products, Inc. Phytoestrogen compositions and associated methods
JP4723849B2 (ja) 2004-11-17 2011-07-13 株式会社ファンケル ダイフラクトースアンハイドライド含有経口組成物
US7989486B2 (en) * 2004-12-30 2011-08-02 Bioresponse, L.L.C. Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions
CA2593335A1 (en) * 2005-01-10 2006-07-13 Hormos Medical Ltd. The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency
JP2006193459A (ja) * 2005-01-12 2006-07-27 Fancl Corp 血中コレステロール低下用経口組成物
US9579303B2 (en) * 2005-02-15 2017-02-28 Dsm Ip Assets B.V. Compositions containing polysaccharides
US7595078B2 (en) 2005-03-15 2009-09-29 Glanbia Nutritionals Ireland Limited Methods of increasing flaxseed hull recovery and resultant flax products
US7563464B1 (en) 2005-04-22 2009-07-21 Bruce Eric Hudkins Treatment of mucosal membranes utilizing phytoestrogen
US20060280840A1 (en) * 2005-05-24 2006-12-14 Robertson Marion G Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
KR101346504B1 (ko) * 2005-12-06 2013-12-31 오츠카 세이야쿠 가부시키가이샤 에쿠올 함유 대두 배축 발효물 및 그의 제조 방법
ITMI20052516A1 (it) 2005-12-29 2007-06-30 Evultis Sa PROCESSO PER L'ISOLAMENTO DI PèRINCIPI FARMACOLOGICAMENTE ATTIVI DI ORIGINE VEGETALE ED ANIMALE
US20070203227A1 (en) * 2006-02-24 2007-08-30 Herman Adlercreutz Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
EP1842541A1 (de) * 2006-03-29 2007-10-10 G.I.M.-Gesellschaft Für Innovative Medizin Gmbh Nfg Ohg Pflanzenextrakte, pflanzliche Wirkstoffe und ihre Verwendung
EP2009990B1 (de) 2006-04-07 2016-09-21 The Board of Regents of The University of Texas System Verfahren und zusammensetzungen in verbindung mit adenoassoziierten virus-phagenpartikeln
US20080108696A1 (en) 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
US8680140B2 (en) * 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
WO2008039482A2 (en) * 2006-09-26 2008-04-03 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
BRPI0717753B1 (pt) 2006-10-27 2022-04-12 Bioresponse, Llc Uso de uma composição compreendendo 50-250 mg de um ou mais indóis relacionados com dim e um ou mais agentes anti-protozoários, e, composição
WO2008100560A2 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators, associated pharmaceutical compositions and methods of use
WO2008131354A2 (en) * 2007-04-20 2008-10-30 The Curators Of The University Of Missouri Phytoestrogens as regulators of hedgehog signaling and methods of their use in cancer treatment
KR101567105B1 (ko) 2007-06-13 2015-11-06 오츠카 세이야쿠 가부시키가이샤 에쿠올 함유 추출물 및 그의 제조방법, 에쿠올 추출 방법
AU2013203101B2 (en) * 2007-06-13 2015-07-09 Otsuka Pharmaceutical Co., Ltd. Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
US7867524B2 (en) * 2007-10-05 2011-01-11 David Rowland Energizing formulation
US20090176871A1 (en) * 2008-01-07 2009-07-09 Schoenwetter Phillip E Treatments for Domestic Animals Having Sex Hormone Deficiencies Using Soy Germ Isoflavones
US8263140B1 (en) 2008-04-16 2012-09-11 Pom Wonderful, Llc Pomegranate based skin protectant and topical application
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
US7863325B2 (en) * 2008-12-11 2011-01-04 Axcentua Pharmaceuticals Ab Crystalline genistein sodium salt dihydrate
EP2373326B1 (de) 2008-12-11 2016-03-09 Axcentua Pharmaceutucals AB Kristalline formen von genistein
JP2013530207A (ja) * 2010-07-07 2013-07-25 カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ NF−κB遺伝子発現を阻害する方法
US20150290271A1 (en) * 2010-07-12 2015-10-15 Frutarom Switzerland Ltd. Nutraceutical Composition Obtained from Fungus-Challenged Soy Seedlings
JP6051436B2 (ja) * 2011-12-07 2016-12-27 国立研究開発法人産業技術総合研究所 レッドクローバーと亜麻種子由来のエストロゲン類似活性組成物
CN105120876A (zh) * 2013-04-12 2015-12-02 R·L·本特 癌症的治疗
KR20170043245A (ko) * 2015-10-13 2017-04-21 숙명여자대학교산학협력단 카자누스 카잔 추출물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는, 갱년기 증상의 예방 및 치료용 약학적 조성물
EP3402788A1 (de) * 2016-01-15 2018-11-21 Universität Hamburg Verbindungen vom flavonoidtyp mit einem o-rhamnosyl-rückstand
US10039765B1 (en) 2016-02-26 2018-08-07 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
US10617700B1 (en) 2016-02-26 2020-04-14 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
TWI774660B (zh) * 2016-03-08 2022-08-21 日商大塚製藥股份有限公司 女性特有之身體及/或精神不快症狀之改善劑
US20210401918A1 (en) * 2018-11-23 2021-12-30 Naturetech Co. Ltd. Composition comprising combination of red clover extract and hops extract for improvement of menopausal disorder
IT201900000343A1 (it) 2019-01-10 2020-07-10 Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35074A (en) * 1862-04-29 Improvement bn snow-plows for railroads
DE1518002C3 (de) 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1543749A1 (de) 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
DK140447B (da) 1970-10-06 1979-08-27 Risoe Forsoegsanlaeg Apparat til kortlægning af tværsnitsdimensionerne for rørformede emner.
JPS54734B2 (de) 1973-05-14 1979-01-16
US3973608A (en) 1973-08-01 1976-08-10 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Microbial production of certain isoflavones
JPS576427B2 (de) 1974-01-25 1982-02-04
HU168753B (de) * 1974-05-03 1976-07-28
JPS50160483A (de) 1974-06-19 1975-12-25
GB1495189A (en) 1975-09-12 1977-12-14 Pfizer Ltd 4-oxo-4h-benzopyran derivatives and process for their preparation
DE2643800C2 (de) 1976-09-29 1986-10-30 Fritz Werner Industrie-Ausrüstungen GmbH, 6222 Geisenheim Verfahren zur Herstellung von Xylose durch enzymatische Hydrolyse von Xylanen
US4157984A (en) 1977-06-08 1979-06-12 Z-L Limited Antioxidants, antioxidant compositions and methods of preparing and using same
US4264509A (en) * 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4232122A (en) 1979-01-17 1980-11-04 Z-L Limited Partnership Antioxidants, antioxidant compositions and methods of preparing and using same
SU907060A1 (ru) 1979-02-07 1982-02-23 Всесоюзный Научно-Исследовательский Биотехнический Институт Способ получени розового масла
US4390559A (en) 1979-04-11 1983-06-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4366082A (en) * 1979-04-11 1982-12-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
US4379177A (en) * 1979-07-05 1983-04-05 The Procter & Gamble Company Stable dehydrated cocrystalline amino acid food additives
JPS5933232A (ja) 1982-08-19 1984-02-23 Tokiwa Kanpou Seiyaku:Kk マメ科植物からサポニン類およびフラボン類の分離方法
US4935450A (en) 1982-09-17 1990-06-19 Therapeutical Systems Corporation Cancer therapy system for effecting oncolysis of malignant neoplasms
US4557927A (en) 1983-03-10 1985-12-10 Kabushiki Kaisha Hoyashibara Food products and process for producing same
JPS59199630A (ja) * 1983-04-26 1984-11-12 Takeda Chem Ind Ltd 卵巣機能低下症治療剤
JPS6048924A (ja) * 1983-08-24 1985-03-16 Takeda Chem Ind Ltd 骨粗鬆症治療剤
JPS6054379A (ja) * 1983-09-05 1985-03-28 Takeda Chem Ind Ltd 新規4h−1−ベンゾピラン−4−オン誘導体,その製法および用途
JPS61106016A (ja) 1984-10-27 1986-05-24 三菱電機株式会社 ガス絶縁母線
DE3604575A1 (de) 1985-02-23 1986-08-28 Degussa Ag, 6000 Frankfurt Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
JPS61247396A (ja) 1985-04-24 1986-11-04 Yamanouchi Pharmaceut Co Ltd ゲニステインの製造法
JPS61246124A (ja) 1985-04-24 1986-11-01 Yamanouchi Pharmaceut Co Ltd 制癌剤
JPS62106016A (ja) * 1985-11-01 1987-05-16 Yamanouchi Pharmaceut Co Ltd 免疫抑制剤
JPS62106017A (ja) 1985-11-01 1987-05-16 Yamanouchi Pharmaceut Co Ltd 抗腫瘍剤
JPS62126286A (ja) 1985-11-25 1987-06-08 Honda Motor Co Ltd ベ−ン式回転圧縮機に於けるベ−ン構造
JPS62126186A (ja) * 1985-11-28 1987-06-08 Tsumura Juntendo Inc イソフラボン誘導体含有溶液の製造方法
GB8626344D0 (en) 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
JPS6442427A (en) 1987-08-10 1989-02-14 Tsumura & Co Sialidase inhibitor
US4900693A (en) 1987-12-21 1990-02-13 United Technologies Process for making polysilicon field plate with improved suppression of parasitic transistors
JPH0832632B2 (ja) 1988-03-08 1996-03-29 株式会社太田胃散 尿素窒素代謝改善剤
JPH0714927B2 (ja) 1988-04-06 1995-02-22 キッコーマン株式会社 イソフラボン化合物の製造法
JPH0267218A (ja) * 1988-08-31 1990-03-07 Nagakura Seiyaku Kk ウイルス・ゲノム不活化剤
JPH0269165A (ja) 1988-09-02 1990-03-08 Mitsugi Ohashi 癌抑制食品
JPH02124883A (ja) 1988-11-04 1990-05-14 Kitasato Inst:The 抗酸化作用を有するイソフラボン誘導体およびその製造法
JP2753719B2 (ja) * 1988-12-15 1998-05-20 日本油脂株式会社 リポソーム製剤の製造法
JPH0347049A (ja) 1989-03-09 1991-02-28 Sanyu:Kk 豆腐廃液ゆからの食品素材及び健康飲料の製造方法
US5153230A (en) 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
CH679584A5 (de) * 1989-11-10 1992-03-13 Nestle Sa
KR0149172B1 (ko) 1990-04-06 1998-10-15 기율라스주크, 타마스스주츠 치환 이소플라본 유도체의 개량된 제조방법
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse
GB2261671B (en) 1991-11-16 1996-07-03 Gb Biotech Gel production from plant matter
JPH05170756A (ja) 1991-12-20 1993-07-09 Kikkoman Corp イソフラボン化合物の製造法
JPH07506822A (ja) * 1992-05-19 1995-07-27 ノボゲン リサーチ ピーティーワイ リミッテッド フィト−エストロゲン,類似体またはその代謝産物を含有する健康補助剤
JPH0686682A (ja) 1992-07-23 1994-03-29 Kobe Steel Ltd 4’,7,8−トリヒドロキシイソフラボンの製造方法
JPH0640909A (ja) 1992-07-23 1994-02-15 Kobe Steel Ltd スーパーオキシド・ディスムターゼ様活性剤
JPH0640876A (ja) 1992-07-23 1994-02-15 Kobe Steel Ltd 紫外線障害防御外用剤
US5301251A (en) * 1992-12-15 1994-04-05 Alcatel Network Systems, Inc. Method and apparatus for affixing an optic fiber tip in position with respect to a fiber communications circuit
CA2160371A1 (en) 1993-04-16 1994-10-27 The Trustees Of Tufts College Method for treatment of menopausal and premenstrual symptoms
JPH06321752A (ja) 1993-05-07 1994-11-22 Kao Corp 美白剤
RU2142957C1 (ru) 1993-10-12 1999-12-20 Протеин Текнолоджиз Интернэшнл, Инк. Способ получения экстракта, обогащенного изофлавоном аглюкона
US5320949A (en) * 1993-10-12 1994-06-14 Protein Technologies International, Inc. Process for producing aglucone isoflavone enriched vegetable protein fiber
KR100303909B1 (ko) 1993-10-12 2001-11-30 캐더린 엘. 해리스 아글루콘 이소플라본이 농후한 식물성 단백질 훼이,훼이단백질및이의생산방법
US5885632A (en) * 1993-12-14 1999-03-23 Nichimo Co., Ltd. Process for preparing a product from a pulse crop as a starting material and a food containing the product prepared from a pulse crop as a starting material
JP3078694B2 (ja) 1993-12-17 2000-08-21 キッコーマン株式会社 ゲニステインの製造法
IL112061A (en) 1994-01-13 1999-10-28 Bristol Myers Squibb Co Methods for the preparation of taxanes
US6369103B1 (en) 1994-01-18 2002-04-09 Bristol-Myers Squibb Company Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
US5366082A (en) * 1994-01-25 1994-11-22 Haytayan Harry M Nail support strips
IL112639A0 (en) 1994-03-11 1995-05-26 Bristol Myers Squibb Co A pharmaceutical composition containing pravastin
US5506211A (en) 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5424331A (en) * 1994-06-10 1995-06-13 Bio-Virus Research Incorporated Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
US5547866A (en) 1994-07-20 1996-08-20 The Regents Of The University Of California Taxane production in haploid-derived cell cultures
DE4432947C2 (de) 1994-09-16 1998-04-09 New Standard Gmbh Mittel zur Behandlung der Haut und seine Verwendung
WO1996010341A1 (en) * 1994-10-03 1996-04-11 Schouten Industries B.V. Food and health products
US5516528A (en) 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5523087A (en) 1995-02-15 1996-06-04 Bio-Virus Research Incorporated Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
US5679806A (en) 1995-02-24 1997-10-21 Hauser, Inc. Process for the isolation and purification of isoflavones
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
JPH08283283A (ja) 1995-04-14 1996-10-29 Kikkoman Corp マロニルイソフラボン配糖体及び該物質からイソフラボン配糖体又はイソフラボンアグリコンを取得する方法
US5639785A (en) 1995-06-07 1997-06-17 Global Pharma, Ltd. Methods for the treatment of baldness and gray hair using isoflavonoid derivatives
US5554519A (en) 1995-08-07 1996-09-10 Fermalogic, Inc. Process of preparing genistein
JPH0967362A (ja) 1995-09-01 1997-03-11 Sankyo Co Ltd 5α−還元酵素阻害剤ビスイソフラボン類
US5702752A (en) 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5821361A (en) 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
JPH1059956A (ja) 1996-08-22 1998-03-03 Kikkoman Corp 新規イソフラボン誘導体及びその製造法
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US5726034A (en) 1996-09-06 1998-03-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
US5804234A (en) 1996-09-13 1998-09-08 Suh; John D. Plant protein for nutritional products and method of making same
US5733926A (en) 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
US6146668A (en) * 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
EP0979074A4 (de) 1997-05-01 2003-07-09 Novogen Inc Behandlung oder vorbeugung klimakteriumsymptomen und der osteoporose
US6060070A (en) 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
US5855892A (en) 1997-09-19 1999-01-05 Potter; Susan M. Method for decreasing LDL-cholesterol concentration and increasing HDL-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
US5942539A (en) 1997-10-03 1999-08-24 Wake Forest University Methods of treating or preventing endometriosis with phytoestrogens
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
US6004558A (en) 1998-02-25 1999-12-21 Novogen, Inc. Methods for treating cancer with legume plant extracts
US6132795A (en) 1998-03-15 2000-10-17 Protein Technologies International, Inc. Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material
CN1293564A (zh) 1998-03-16 2001-05-02 宝洁公司 调节皮肤外观的方法
AUPP260798A0 (en) 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPP868599A0 (en) * 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
US6544566B1 (en) 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US20040072765A1 (en) 1999-04-28 2004-04-15 Novogen Research Pty Ltd. Cardiovascular and bone treatment using isoflavones
AUPQ266199A0 (en) 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ520300A0 (en) 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
AUPR255401A0 (en) 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
AUPR363301A0 (en) 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones

Also Published As

Publication number Publication date
US6987098B2 (en) 2006-01-17
US20040048812A1 (en) 2004-03-11
US20070179099A1 (en) 2007-08-02
US6497906B1 (en) 2002-12-24
US5830887A (en) 1998-11-03
DK0656786T3 (da) 2004-11-08
EP1477178A3 (de) 2005-02-16
USRE40792E1 (en) 2009-06-23
CA2136233A1 (en) 1993-11-25
US7045155B2 (en) 2006-05-16
NO944435D0 (no) 1994-11-18
CA2136233C (en) 2004-03-30
EP1477178A2 (de) 2004-11-17
US20030078214A1 (en) 2003-04-24
US6562380B1 (en) 2003-05-13
NZ252051A (en) 1996-10-28
EP0656786A4 (de) 1997-06-11
WO1993023069A1 (en) 1993-11-25
BR9306393A (pt) 1998-09-15
ATE275959T1 (de) 2004-10-15
EP0656786A1 (de) 1995-06-14
US20120003337A1 (en) 2012-01-05
DE69333624T2 (de) 2005-09-15
US20040170713A1 (en) 2004-09-02
PT656786E (pt) 2004-11-30
US6642212B1 (en) 2003-11-04
JPH07506822A (ja) 1995-07-27
US20110305782A1 (en) 2011-12-15
US20040106561A1 (en) 2004-06-03
JP2004002304A (ja) 2004-01-08
EP0656786B1 (de) 2004-09-15
NO944435L (no) 1994-11-18
AU4052593A (en) 1993-12-13
EP0656786B2 (de) 2014-04-23
ES2225822T3 (es) 2005-03-16
AU683838B2 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
DE69333624D1 (de) Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee
BR9909105A (pt) Terapia de distúrbios associados ao estrogênio descrição
ATE264093T1 (de) Sojazubereitungen und deren verwendung zur gesundheitsförderung
KR970703746A (ko) 육모제(hair growth stimulant)
PT100800A (pt) Composicoes para clareamento da pele, a base de flavonoide e de acido ascorbico ou seu derivado
BR9916879A (pt) Composição e método para tratamento do câncer utilizando óleos essenciais vegetais naturais
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
DE58903810D1 (de) Einrichtung zur behandlung eines knochens, insbesondere kieferknochens, und/oder zahns.
EP0903143A3 (de) Verwendung von Daidzein zur Herstellung eines Arzneimittels zur Erhöhung des HDL Cholesterolniveaus
NO20075066L (no) Farmasoytisk sammensetning som inneholder isoflavoner
ATE334978T1 (de) Zusammensetzungen und therapeutische anwendungen von isoflavonen und deren analoga
DE69908809D1 (de) Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
NZ513328A (en) Cardiovascular and bone treatment composition comprising formononetin and one or more other isoflavone
HK1069327A1 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
DE3767849D1 (de) Arzneimittel zur vorbeugung und behandlung der alkoholischen toxicomanie und verfahren zu ihrer herstellung.
ES2195939T3 (es) Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba.
DE69635754D1 (de) Medikamente zur verhinderung von eingriffsbedingter stenose als folge von nicht-bypass invasiver eingriffe
ATE220860T1 (de) Zusammensetzung zur unterdrückung von entzugssymptomen und alkoholabhängigkeit bei alkoholikern sowie prävention von alkoholmissbrauch bei gesunden personen
DE59000530D1 (de) Anordnung zur behandlung und/oder reinigung von gut, insbesondere von mit bohrungen versehenen leiterplatten (fall a).
DE68905973T2 (de) Synergistische suessungsmittel-zusammensetzungen, enthaltend chlorodeoxysucrase, und diese enthaltende zusammensetzungen.
ATE160349T1 (de) Antihypertensive benzopyran-derivate
ES2045008T3 (es) Procedimiento para la obtencion de preparados en combinacion antidepresivos.
RO103683A2 (en) Treatment medicine for eczema
DE69009989D1 (de) Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: NOVOGEN RESEARCH PTY. LTD., NORTH RYDE, NEUSUEDWALE

8381 Inventor (new situation)

Inventor name: INVENTOR IS APPLICANT

8363 Opposition against the patent